Research ReportDecreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain
Highlights
► Diminished hematocrit in chronic moderate hyperoxia in mice. ► VEGF, Flk-1 and PGC-1α expression was decreased in hyperoxia. ► HIF-α, EPO, COX-2 and Ang-2 expression was increased in hyperoxia. ► Brain microvascularity was decreased in prolonged moderate hyperoxia.
Introduction
The brain has a high metabolic rate; its oxygen demand exceeds that of all other organs except the heart (Diringer, 2008). Although oxygen is essential for animal survival, it may become toxic at an elevated partial pressure (Allen et al., 2009, Archibald, 2003). The cells of the brain, especially neurons, are vulnerable to the deleterious effects of excessive reactive oxygen species (ROS) produced during hypoxic and hyperoxic oxidative stress (Bitterman, 2004, Lee et al., 2005). Hence, the partial pressure of oxygen in the brain parenchyma is tightly controlled, and normal brain function is delicately sensitive to continuous and controlled oxygen delivery (Dore-Duffy and LaManna, 2007).
The brain maintains its optimal continuous supply of oxygen and nutrients by systemic and brain physiologic and angiogenic adaptational changes (Boero et al., 1999). Angiogenesis is a complex process which requires the coordinated production and interaction of multiple vascular regulating factors among which HIF, VEGF, COX-2 and Ang-2 are the critical ones (Carmeliet, 2003, Pichiule and LaManna, 2002). The oxygen-sensing HIF/PHD/VHL dependent pathway plays a central role in cellular adaptation to oxygen fluctuations (Jaakkola et al., 2001, Miro-Murillo et al., 2011, Mole and Ratcliffe, 2008). Under normoxic conditions PHD hydroxylates prolyl residues in the HIF-α subunits that are then recognized by the VHL-E3 ubiquitin ligase complex that marks them for degradation by the proteasome (Ivan et al., 2001, Mole and Ratcliffe, 2008). Various factors including hypoxia, growth factors, ROS, ketosis, and increase in extracellular pH (acidosis) are known to induce accumulation of HIF-α (Lopez-Lazaro, 2006, Lu et al., 2002, Lum et al., 2007, Mekhail et al., 2004, Puchowicz et al., 2008). When HIF-α accumulates in the cytoplasm it translocates into the nucleus and binds with the HIF-β subunit to form active HIF, which promotes expression of genes that contain hypoxia-response element (HRE) and that are involved in cellular response to the adverse milieu (Ivan et al., 2001, Jaakkola et al., 2001).
The VEGF and EPO genes are among those that are inducible by HIF (Berra et al., 2003, Semenza, 2007). VEGF-A is a potent endothelial cell mitogen and a key regulator of physiological and pathological angiogenesis (Ferrara et al., 2003). It acts through two distinct tyrosine kinase receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1), and is essential for endothelial cell differentiation as well as the sprouting of new capillaries from preexisting vessels (Ferrara et al., 2003, Hosford and Olson, 2003). Flk-1 appears to be the dominant signaling receptor mediating angiogenesis, whereas the much weaker Flt-1 appears to be involved in VEGF autoregulation (Brekken et al., 2000, Shibuya, 2001). In the brain, HIF-1α is known to be involved in angiogenesis through induction of VEGF, though VEGF expression is also known to be induced by PGC-1α, independent of HIF-1α (Arany et al., 2008, Benderro and LaManna, 2011, Chinsomboon et al., 2009, Ndubuizu et al., 2010). In adults, systemic EPO is mainly produced by the kidneys and in small amounts by the liver, and is essential for maintenance of tissue oxygen homeostasis by stimulating red blood cell production (Fisher, 2003). There is also paracrine EPO production in the brain parenchyma (Bartesaghi et al., 2005, Rabie and Marti, 2008). It has been demonstrated that HIF-2α is the main regulator of brain erythropoietin production, which is known to be a key neuroprotective factor in central nervous system (Chavez et al., 2006, Ponce et al., 2012, Rabie and Marti, 2008, Xiong et al., 2011). As a neuroprotective agent, EPO antagonizes glutamate cytotoxic action, enhances antioxidant enzyme expression and reduces the free radical production rate (Bartesaghi et al., 2005).
The COX-2/Ang-2 pathway is also essential during stress responses and angiogenic remodeling (Liang and Jiang, 2009, Wilkinson-Berka et al., 2003). Ang-2 induction is known to occur mainly by COX-2 enzyme activities, independent of the HIF induction pathway (Pichiule et al., 2004). Ang-2 appears to be an important signaling molecule during vascular remodeling, both increases and decreases in microvascular density (Dore-Duffy and Lamanna, 2007). During vascular remodeling Ang-2 causes destabilization of microvessels, and if a sufficient amount of VEGF is present subsequent endothelial cell growth, proliferation, and formation of capillary sprouts leads to angiogenesis. However, with an insufficient amount or absence of VEGF, the activities of Ang-2 lead capillaries to undergo apoptotic regression (Pichiule and LaManna, 2002). Ang-2 is expressed at low levels in most normal adult brain, but is strongly upregulated during hypoxia, re-oxygenation after hypoxia and at sites of active vessel remodeling, such as ovarian and tumor tissues (Carmeliet, 2003). It is upregulated at times of both growth and regression, suggesting that it plays an active role in angioplasticity (Koh et al., 2002). Also there are reports showing an increase in COX-2 and Ang-2 expression in rodent lungs, retina and cerebral cortex in response to oxidative stress in acute hyperoxia (Bhandari et al., 2006, Liang and Jiang, 2009, Perez-Polo et al., 2011). However, influence of chronic hyperoxia on COX-2 and Ang-2 expression and comparative effects through the HIF/VEGF pathway, and microvascular density in the brain have not been defined.
There are numerous reports on the effects of short term hyperbaric and normobaric hyperoxia on the brain, but effects of chronic hyperoxia on brain acclimatization changes (molecular, structural or angiogenic) have not been established. Hence, in this study we investigated the effects of chronic moderate normobaric hyperoxia (50% O2) on expression of the main angiogenic growth factors and their activities on brain vascular remodeling. Increasing oxygen partial pressure tends to produce an increased vasoconstrictive tone which somewhat limits the overall levels to which brain tissue oxygen tension rises, but does not reverse it. Measurements of tissue oxygen partial pressure demonstrated increased oxygen and increased hemoglobin oxygen saturation (Bulte et al., 2007, Demchenko et al., 2000, Duong et al., 2001, LaManna, 2007).
We previously showed that lowering oxygen in the inspired air led to angiogenesis, suggesting a modulatory role for oxygen in determining capillary density (Benderro and LaManna, 2011, Ndubuizu et al., 2010, Pichiule and LaManna, 2002). These observations led to the question whether capillary density was proportional to oxygen delivery and whether the main mechanism linking tissue oxygen partial pressure and capillary density was the HIF/VEGF pathway. The results demonstrate that hyperoxia does indeed result in decreased capillary density consistent with a fall in VEGF, but also showed a seemingly paradoxical increase in HIF-1 and 2α accumulation. HIF-1α mRNA levels were not affected, but PHD-2 expression was diminished in chronic hyperoxia suggesting that HIF-α accumulation, leading to upregulation of EPO, was due to reduced posttranslational degradation. Decreased VEGF expression could have been due to a decrease in PGC-1α, implying the importance of this molecule in the VEGF induction pathway. The remodeling signaling, COX-2 and Ang-2, protein levels were also upregulated.
Section snippets
Change in body weight, hematocrit and arterial Blood oxygen saturation during hyperoxia
All mice kept in 50% oxygen normobaric hyperoxia for up to 3 weeks survived throughout hyperoxic exposure. Compared to their normoxic littermates the mice in hyperoxia tended toward a stunted body weight increase. But the difference in body weight between normoxic and hyperoxic mice throughout 3 week exposure did not reach statistical significance (Fig. 1A and B). Hematocrit was significantly decreased (p<0.05) at day 4 and beyond, of hyperoxic exposure (Fig. 1C). The hematocrit values
Discussion
The primary finding in this study was that chronic hyperoxic exposure leads to brain capillary regression and decreased microvascular density. Considered with the previous finding of angiogenesis and increased capillary density during chronic hypoxic exposure, this study strongly implies that brain capillary density is proportional to stable ambient oxygen availability.
Vascular remodeling is a fundamental physiological process during development and acclimatization to adverse environments (
Exposure to chronic hyperoxia
Male 4-month old C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and maintained at the Case Western Reserve University Animal Care Facility for at least a week before experiments. The experimental protocol was approved by the Institutional Animal Care and Use Committee. Mice that were exposed to hyperoxia were placed in a normobaric chamber (Oxycycler™; BioSpherix Ltd., Lacona, NY), to which computer regulated 50% O2 was supplied for up to 3 weeks. The littermate,
Acknowledgment
This study was supported by National Institutes of Health grant NS-38632.
References (59)
- et al.
Endothelial Akt activation by hyperoxia: role in cell survival
Free Radic. Biol. Med.
(2006) - et al.
Erythropoietin: a novel neuroprotective cytokine
Neurotoxicology
(2005) - et al.
Hypoxia-induced angiogenesis is delayed in aging mouse brain
Brain Res.
(2011) - et al.
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
Exp. Cell Res
(2006) - et al.
Moderate hyperoxia (40%) increases antioxidant levels in mouse tissue
J. Surg. Res.
(2005) - et al.
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
J. Biol. Chem.
(2002) - et al.
Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain
Brain Res.
(2010) - et al.
Oxygen resuscitation after hypoxia ischemia stimulates prostaglandin pathway in rat cortex
Int. J. Dev. Neurosci.
(2011) - et al.
Hypoxic regulation of angiopoietin-2 expression in endothelial cells
J. Biol. Chem.
(2004) Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
Int. J. Biochem. Cell Biol
(2001)
Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo
Lab. Invest
HIF-1alpha expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity
J. Neuroimmunol.
Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity
J. Appl. Physiol.
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha
Nature
Oxygen toxicity and the health and survival of eukaryote cells: a new piece is added to the puzzle
Proc. Natl. Acad. Sci. USA
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
EMBO J.
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death
Nat. Med
The role of angiopoietin 2 in hyperoxia-induced acute lung injury
Cell Cycle
CNS oxygen toxicity
Undersea Hyperb. Med.
Increased brain capillaries in chronic hypoxia
J. Appl. Physiol.
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice
Cancer Res.
Cerebral perfusion response to hyperoxia
J. Cereb. Blood Flow Metab.
Angiogenesis in health and disease
Nat. Med
The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes
J. Neurosci.
The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle
Proc. Natl. Acad. Sci. USA
Nitric oxide and cerebral blood flow responses to hyperbaric oxygen
J. Appl. Physiol.
Hyperoxia: good or bad for the injured brain?
Curr. Opin. Crit. Care
Physiologic angiodynamics in the brain
Antioxid. Redox Signal.
Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow
Magn. Reson. Med.
Cited by (57)
High glucose conditioned neonatal astrocytes results in impaired mitogenic activity in cerebral microvessel endothelial cells in co-culture
2019, HeliyonCitation Excerpt :Reaction systems were 3μl Bulls eye TaqProbe 2X qPCR MasterMix-Low Rox (#BEQPCR-PL, Midwest scientific, Valley Park, MO), 2 μl Primer-Probe (diluted from 20X, see following for detail), 1 μl cDNA (1:20 dilution), loading to MicroAmp Optical 384-well reaction plate (#4309849, Applied Biosystems, Foster City, CA). Applied primers were GAPDH (Ref Seq #NM_017008 [1], Assy ID: Rn.PT.58.35727291, Integrated DNA Technologies, Inc. (IDT), Skokie, IL), VEGF (exon 1b-4) (Ref Seq #NM_001110333 [3], Assay ID: Rn.PT.58.34097147, IDT, Skokie, IL). PCR runs: hot start 10 minutes at 95 °C followed by 40 cycles of 10 sections at 95 °C and 60 sections at 60 °C, terminated by cooling to 4 °C.
Hyperoxia improves carbohydrate metabolism by browning of white adipocytes in obese type 2 diabetic rats
2019, Life SciencesCitation Excerpt :Rats in hyperoxia groups were exposed to 95% oxygen (near to normobaric atmosphere) in a hypoxia/hyperoxia chamber (SD-EOS) for 2 h/day (10.00–12.00 AM), all days except Fridays, for 5 weeks (Fig. 1). In this study, 95% oxygen was administrated as it has been reported that doses of oxygen of 50% and 60% have no effect on body weight and enzymes related to glucose metabolism [29,30]. Rats had free access to food and water in the chamber; they were at own cages in the chamber to avoid any stressful condition; Rats in control groups were kept in the animal room under normoxia conditions.
The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance
2024, Current Molecular Pharmacology